5387 |
Optimal Management for Failure TAVR Valve |
Vinayak Bapat |
Apr. 08. 22 |
5386 |
Optimal TAVR Procedure for Bicuspid AV: Self Expandable Device |
Eberhard Grube |
Apr. 08. 22 |
5385 |
Pragmatic Antithrombotic Strategies According to Bleeding and Ischemic Risk |
Duk-Woo Park |
Apr. 08. 22 |
5384 |
Escalation Antithrombotic Strategy: When and How? |
Davide Capodanno |
Apr. 08. 22 |
5383 |
Ischemic and Bleeding Risk Prediction After ACS and PCI |
Sunil Rao |
Apr. 08. 22 |
5382 |
Optimal DAPT Duration for PCI Patients at High Beeding Risk |
Roxana Mehran |
Apr. 08. 22 |
5381 |
Best Stent and Best Antithrombotic Strategy in High Bleeding Risk Patients: MASTER-DAPT, ONYX-ONE, LEADER-FREE and Others |
Marco Valgimigli |
Apr. 08. 22 |
5380 |
Imaging Based Coronary Physiology in the Clinical Practice: CTFFR and AngioFFR |
Bon-Kwon Koo |
Apr. 08. 22 |
5379 |
The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs |
Jung-Min Ahn |
Apr. 08. 22 |
5378 |
When and How to Use Intracoronary Imaging in My Cath Lab |
Do-Yoon Kang |
Apr. 08. 22 |